Chronic hepatitis B and C as stigma: Is the problem relevant for Russian society?


Cite item

Full Text

Abstract

Chronic hepatitis B and C (CHB and CHC) are a serious medical and social problem of the world community. Aim: to study the problem of stigmatization and attitudes to patients with CHB and CHC among adolescents and adults. Materials and methods. An anonymous survey was conducted in 120 residents of the Kirov region. Of these, 94 adults (aged 18 to 76 years; average age 39.3±11.5 years) of different specialties except medical (group 1) and 26 adolescents aged 16-17 years (average age 16.5±0.5 years), high school students (group 2). The original questionnaire included 16 questions divided into 3 blocks. Block 1 contained questions about the socio - demographic status of the Respondent, block 2 and block 3 included questions on the epidemiology of HCV and HBV infection and on the treatment of patients with CHC and CHB respectively. Results. In the course of work the majority of respondents (50-65.4%) from both groups revealed a negative attitude towards patients with CHB and CHC (to a lesser extent pronounced against close relatives and friends of CHC patients), manifested by a desire to exclude casual contact and refusal to live in the same room with the patient CHB/CHC, no desire of sharing your child/brother in the same kindergarten group patients with CHB/CHC child. Fear of Contracting HBV/HCV infection has been linked to poor knowledge of the factors and pathways of transmission of these diseases. In a few cases, adolescents and adults showed an extreme degree of destructive attitude, which was expressed in the adoption of discriminatory measures against this category of patients - dismissal from work and expulsion from school/University. Conclusion. The results indicate that there is a problem of stigmatization of patients with CHB and CHC in society, both in children and adults, which requires systematic work on health education.

About the authors

S V Baramzina

Kirov State Medical University Department of Infectious Diseases

к.м.н., доцент каф. инфекционных болезней Кировского государственного медицинского университета Минздрава России Kirov, Russia

References

  1. Глобальная стратегия сектора здравоохранения по вирусному гепатиту на 2016-2021 гг. http://www.who.int/hepatitis/strategy 2016-2021/ghss-hep/ru/ Ссылка активна на 20.11.2018
  2. Роспотребнадзор по Кировской области и РФ. Доступно по: http:// www.43.rospotrebnadzor.ru и http://rospotrebnadzor.ru Ссылка активна на 20.11.2018
  3. Дудник О.В. Качество жизни и возможности его улучшения у больных хроническими гепатитами В и С: автореф. дисс…. канд. мед. наук. М., 2013.
  4. Александров О.В. Влияние социального статуса на качество жизни больных хроническим гепатитом С: автореф. дисс…. канд. мед. наук. Волгоград, 2007.
  5. Шевченко В.В. Психосоматический статус больных вирусными гепатитами В и С на стационарном этапе лечения: автореф. дисс…. канд. мед. наук. С.-Петербург, 2008.
  6. Астапченко Д.С. Социально - клинические проблемы лечения хронического гепатита С. Актуальная инфектология. 2014;2(3). www.mif-ua.com 25.
  7. Барамзина С.В. Оценка осведомленности подростков и взрослых в вопросах эпидемиологии, исходов и терапии хронических гепатитов В и С. Терапевтический архив. 2016;88(11):37-42. doi: 10.17116/terarkh2016881137-42
  8. Новикова Ю.Б., Шуляк Ю.А., Демидович Л.И. и др. Изучение уровня знаний о возможности заражения, лечения и профилактики парентеральных гепатитов В и С и ВИЧ-инфекции среди пациентов наркологического стационара. Эпидемиология и вакцинопрофилактика. 2013;(2):80-6. Доступно по: http://www.epidemvac.ru/ Ссылка активна на 20.11.2018. Dostupno po: http://www.epidemvac.ru/ Ssylka aktivna na 20.11.2018.
  9. Эсауленко Е.В., Сухорук А.А., Захаров К.А. и др. Иммуногенность вакцины против гепатита В третьего поколения (pre-S1/pre-S2/S). Инфекция и иммунитет. 2018;8(1):71-8
  10. Баранов А.В. Эпидемиологические факторы и клинико - иммунологические аспекты патогенеза хронического гепатита С: автореф. дисс…. докт. мед. наук. М., 2009. Доступно по: http://medical-diss.com/medicina Ссылка активна на 20.11.2018. Dostupno po: http://medical-diss.com/medicina. Ssylka aktivna na 20.11.2018.
  11. Ghoda M.K, Shah R.A. A prospective epidemiological study to see if mosquito bite could be responsible for spread of hepatitis B virus infection. Trop Gastroenterol. 2005 Jan-Mar;26(1):29-30.
  12. Houldsworth A. Exploring the possibility of arthropod transmission of HCV. J Med Virol. 2017 Feb;89(2):187-94. doi: 10.1002/jmv.24638. Epub 2016 Sep 2
  13. Kostić М, Koctić В. Stigmatization and discrimination of patients with chronic hepatitis C. Vojnosanit Pregl. 2016;73(12):1116-24.
  14. Crutzen R, Göritz A.S. Public awareness and practical knowledge regarding Hepatitis A, B, and C: a two - country survey. J Infect Public Health. 2012 Apr;5(2):195-8. http://dx.doi.org/10.1016/j.jiph.2011.12.001
  15. Lee H, Fawcett J, Kim D, et al. Correlates of Hepatitis B Virus - related Stigmatization Experienced by Asians: A Scoping Review of Literature. Asia Pac J Oncol Nurs. 2016 Oct-Dec;3(4):324-34. doi: 10.4103/2347-5625.195896
  16. Crofts N, Louie R, Loff B. The next plague: Stigmatization and discrimination related to Hepatitis C virus infection in Australia. Health and Human Rights. 1997;2(2):86-97. http://dx.doi.org/10.2307/4065273
  17. Grundy G, Beeching N. Understanding social stigma in women with hepatitis C. Nursing Standard.2004;19(4):35-9. http://dx.doi.org/10. 7748/ns2004.10.19.4.35.c3720
  18. A National Strategy for Prevention and Control of Hepatitis B and C: Institute of Medicine (US) Committee on the Prevention and Control of Viral Hepatitis Infection; Editors: Heather M. Colvinand Abigail E. Mitchell. Washington (DC): National Academies Press (US), 2010. http://dx.doi.org/10.17226/12793
  19. Барамзина С.В., Брюхович О.М., Окулова Е.О. Оценка уровня стигматизации больных хроническими гепатитами B и C у студентов разных ВУЗов. Эпидемиология и вакцинопрофилактика. 2017;16(3): 72-7. Dostupno po: http://www.epidemvac.ru/ Ssylka aktivna na 20.11.2018.

Copyright (c) 2019 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies